Author Correction: A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability.

Autor: Voigt EA; RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA. emily.voigt@aahi.org., Gerhardt A; Product Development, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA., Hanson D; RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA., Jennewein MF; RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA., Battisti P; RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA., Reed S; Product Development, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA., Singh J; RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA., Mohamath R; Formulation Sciences, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA., Bakken J; RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA., Beaver S; RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA., Press C; Product Development, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA., Soon-Shiong P; ImmunityBio, Inc, Culver City, CA, 90232, USA., Paddon CJ; Amyris, Inc, Emeryville, CA, 94608, USA., Fox CB; Formulation Sciences, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA.; Department of Global Health, University of Washington, Seattle, WA, 98195, USA., Casper C; RNA Vaccines, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA.; Product Development, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA.; Formulation Sciences, Access to Advanced Health Institute (AAHI), Seattle, WA, 98102, USA.; Department of Global Health, University of Washington, Seattle, WA, 98195, USA.; Department of Medicine, University of Washington, Seattle, WA, 98195, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2022 Nov 23; Vol. 7 (1), pp. 150. Date of Electronic Publication: 2022 Nov 23.

Altered Maternal Antibody Profiles in Women With Human Immunodeficiency Virus Drive Changes in Transplacental Antibody Transfer.

Autor: Dolatshahi S; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA., Butler AL; State University of New York Upstate Medical University, Syracuse, New York, USA., Siedner MJ; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Center for Global Health, Massachusetts General Hospital, Boston, Massachusetts, USA., Ngonzi J; Mbarara University of Science and Technology, Mbarara, Uganda., Edlow AG; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts, USA., Adong J; Mbarara University of Science and Technology, Mbarara, Uganda., Jennewein MF; Fred Hutchinson Cancer Center, Seattle, Washington, USA., Atyeo C; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA., Bassett IV; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Roberts DJ; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA., Lauffenburger DA; Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Alter G; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA., Bebell LM; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Center for Global Health, Massachusetts General Hospital, Boston, Massachusetts, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Oct 12; Vol. 75 (8), pp. 1359-1369.

Functional and structural modifications of influenza antibodies during pregnancy.

Autor: Jennewein MF; The Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA., Kosikova M; Laboratory of Pediatric and Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA., Noelette FJ; The Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA., Radvak P; Laboratory of Pediatric and Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA., Boudreau CM; The Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA., Campbell JD; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA., Chen WH; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA., Xie H; Laboratory of Pediatric and Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA., Alter G; The Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA., Pasetti MF; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

Publikováno v: IScience [iScience] 2022 Mar 16; Vol. 25 (4), pp. 104088. Date of Electronic Publication: 2022 Mar 16 (Print Publication: 2022).

Designed proteins assemble antibodies into modular nanocages.

Autor: Divine R; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA., Dang HV; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Ueda G; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA., Fallas JA; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA., Vulovic I; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA., Sheffler W; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA., Saini S; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA., Zhao YT; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.; Oral Health Sciences, School of Dentistry, University of Washington, Seattle, WA 98195, USA., Raj IX; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA., Morawski PA; Benaroya Research Institute, Seattle, WA 98101, USA., Jennewein MF; Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98019, USA., Homad LJ; Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98019, USA., Wan YH; Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98019, USA., Tooley MR; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA., Seeger F; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA., Etemadi A; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Medical Biotechnology Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran., Fahning ML; Benaroya Research Institute, Seattle, WA 98101, USA., Lazarovits J; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA., Roederer A; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA., Walls AC; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Stewart L; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA., Mazloomi M; Medical Biotechnology Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran., King NP; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA., Campbell DJ; Benaroya Research Institute, Seattle, WA 98101, USA., McGuire AT; Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98019, USA.; Department of Global Health, University of Washington, Seattle, WA 98195, USA., Stamatatos L; Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98019, USA.; Department of Global Health, University of Washington, Seattle, WA 98195, USA., Ruohola-Baker H; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA., Mathieu J; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.; Department of Comparative Medicine, University of Washington, Seattle, WA 98195, USA., Veesler D; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Baker D; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA. dabaker@uw.edu.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.

Publikováno v: Science (New York, N.Y.) [Science] 2021 Apr 02; Vol. 372 (6537).

A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.

Autor: Stamatatos L; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA., Czartoski J; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Wan YH; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Homad LJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Rubin V; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Glantz H; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Neradilek M; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Seydoux E; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Jennewein MF; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., MacCamy AJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Feng J; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Mize G; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., De Rosa SC; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Finzi A; Centre de Recherche du CHUM, Montréal, QC, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada.; Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada., Lemos MP; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Cohen KW; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Moodie Z; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., McElrath MJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA., McGuire AT; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2021 Mar 10. Date of Electronic Publication: 2021 Mar 10.